Filtros : "CANNABIS" "Guimarães, Francisco Silveira" "Holanda" Removidos: "Capelozzi, Vera Luzia" "Andraus, Maristela Haddad" "Physiology Limpar

Filtros



Refine with date range


  • Source: Behavioural Brain Research. Unidades: FMRP, FCFRP

    Subjects: ANTIDEPRESSIVOS, CANNABIS, NEUROCIÊNCIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SARTIM, Ariandra Guerini e GUIMARÃES, Francisco Silveira e JOCA, Sâmia Regiane Lourenço. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex: possible involvement of 5-HT1A and CB1 receptors. Behavioural Brain Research, v. 303, p. 218-227, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2016.01.033. Acesso em: 24 jul. 2024.
    • APA

      Sartim, A. G., Guimarães, F. S., & Joca, S. R. L. (2016). Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex: possible involvement of 5-HT1A and CB1 receptors. Behavioural Brain Research, 303, 218-227. doi:10.1016/j.bbr.2016.01.033
    • NLM

      Sartim AG, Guimarães FS, Joca SRL. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex: possible involvement of 5-HT1A and CB1 receptors [Internet]. Behavioural Brain Research. 2016 ; 303 218-227.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.bbr.2016.01.033
    • Vancouver

      Sartim AG, Guimarães FS, Joca SRL. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex: possible involvement of 5-HT1A and CB1 receptors [Internet]. Behavioural Brain Research. 2016 ; 303 218-227.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.bbr.2016.01.033
  • Source: European Neuropsychopharmacology. Unidade: FMRP

    Subjects: CÓRTEX PRÉ-FRONTAL, CANNABIS, ANSIEDADE SOCIAL, ESTRESSE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FOGAÇA, M. V. et al. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of '5HT IND.1A' receptors and previous stressful experience. European Neuropsychopharmacology, v. 24, n. 3, p. 410-419, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2013.10.012. Acesso em: 24 jul. 2024.
    • APA

      Fogaça, M. V., Reis, F. M. C. V., Campos, A. C., & Guimarães, F. S. (2014). Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of '5HT IND.1A' receptors and previous stressful experience. European Neuropsychopharmacology, 24( 3), 410-419. doi:10.1016/j.euroneuro.2013.10.012
    • NLM

      Fogaça MV, Reis FMCV, Campos AC, Guimarães FS. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of '5HT IND.1A' receptors and previous stressful experience [Internet]. European Neuropsychopharmacology. 2014 ; 24( 3): 410-419.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.euroneuro.2013.10.012
    • Vancouver

      Fogaça MV, Reis FMCV, Campos AC, Guimarães FS. Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of '5HT IND.1A' receptors and previous stressful experience [Internet]. European Neuropsychopharmacology. 2014 ; 24( 3): 410-419.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.euroneuro.2013.10.012
  • Source: Current Neuropharmacology. Unidade: FMRP

    Subjects: NEURÔNIOS (FORMAÇÃO), ANTIDEPRESSIVOS, CANNABIS, NEUROFARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FOGAÇA, Manoela Viar et al. Cannabinoids, neurogenesis and antidepressant drugs: is there a link?. Current Neuropharmacology, v. 11, n. 3, p. 263-275, 2013Tradução . . Disponível em: https://doi.org/10.2174/1570159X11311030003. Acesso em: 24 jul. 2024.
    • APA

      Fogaça, M. V., Galve-Roperh, I., Guimarães, F. S., & Campos, A. C. (2013). Cannabinoids, neurogenesis and antidepressant drugs: is there a link? Current Neuropharmacology, 11( 3), 263-275. doi:10.2174/1570159X11311030003
    • NLM

      Fogaça MV, Galve-Roperh I, Guimarães FS, Campos AC. Cannabinoids, neurogenesis and antidepressant drugs: is there a link? [Internet]. Current Neuropharmacology. 2013 ; 11( 3): 263-275.[citado 2024 jul. 24 ] Available from: https://doi.org/10.2174/1570159X11311030003
    • Vancouver

      Fogaça MV, Galve-Roperh I, Guimarães FS, Campos AC. Cannabinoids, neurogenesis and antidepressant drugs: is there a link? [Internet]. Current Neuropharmacology. 2013 ; 11( 3): 263-275.[citado 2024 jul. 24 ] Available from: https://doi.org/10.2174/1570159X11311030003
  • Source: Current Phamaceutical Design. Unidade: FMRP

    Subjects: CANNABIS, ANTIPSICÓTICOS, TRANSTORNOS PSICÓTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ZUARDI, Antonio Waldo et al. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Current Phamaceutical Design, v. 18, n. 32, p. 5131-5140, 2012Tradução . . Disponível em: https://doi.org/10.2174/138161212802884681. Acesso em: 24 jul. 2024.
    • APA

      Zuardi, A. W., Crippa, J. A. de S., Hallak, J. E. C., Bhattacharyya, S., Atakan, Z., Martín-Santos, R., et al. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation. Current Phamaceutical Design, 18( 32), 5131-5140. doi:10.2174/138161212802884681
    • NLM

      Zuardi AW, Crippa JA de S, Hallak JEC, Bhattacharyya S, Atakan Z, Martín-Santos R, McGuire PK, Guimarães FS. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 5131-5140.[citado 2024 jul. 24 ] Available from: https://doi.org/10.2174/138161212802884681
    • Vancouver

      Zuardi AW, Crippa JA de S, Hallak JEC, Bhattacharyya S, Atakan Z, Martín-Santos R, McGuire PK, Guimarães FS. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Internet]. Current Phamaceutical Design. 2012 ; 18( 32): 5131-5140.[citado 2024 jul. 24 ] Available from: https://doi.org/10.2174/138161212802884681
  • Source: Behavioural Brain Research. Unidade: FMRP

    Subjects: CÓRTEX PRÉ-FRONTAL, CANNABIS, ANSIEDADE, ANSIOLÍTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LEMOS, José Inácio e RESSTEL, Leonardo Barbosa e GUIMARÃES, Francisco Silveira. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behavioural Brain Research, v. 207, n. 1, p. 105-111, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.bbr.2009.09.045. Acesso em: 24 jul. 2024.
    • APA

      Lemos, J. I., Resstel, L. B., & Guimarães, F. S. (2010). Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behavioural Brain Research, 207( 1), 105-111. doi:10.1016/j.bbr.2009.09.045
    • NLM

      Lemos JI, Resstel LB, Guimarães FS. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats [Internet]. Behavioural Brain Research. 2010 ; 207( 1): 105-111.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.bbr.2009.09.045
    • Vancouver

      Lemos JI, Resstel LB, Guimarães FS. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats [Internet]. Behavioural Brain Research. 2010 ; 207( 1): 105-111.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.bbr.2009.09.045
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: ANSIEDADE, CANNABIS, NEUROTRANSMISSORES

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LISBOA, Sabrina F. et al. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test. European Journal of Pharmacology, v. 593, n. 1-3, p. 73-78, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.07.032. Acesso em: 24 jul. 2024.
    • APA

      Lisboa, S. F., Resstel, L. B. M., Aguiar, D. C., & Guimarães, F. S. (2008). Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test. European Journal of Pharmacology, 593( 1-3), 73-78. doi:10.1016/j.ejphar.2008.07.032
    • NLM

      Lisboa SF, Resstel LBM, Aguiar DC, Guimarães FS. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test [Internet]. European Journal of Pharmacology. 2008 ; 593( 1-3): 73-78.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.ejphar.2008.07.032
    • Vancouver

      Lisboa SF, Resstel LBM, Aguiar DC, Guimarães FS. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects rats submitted to the Vogel conflict test [Internet]. European Journal of Pharmacology. 2008 ; 593( 1-3): 73-78.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.ejphar.2008.07.032
  • Source: European Journal of Pharmacology. Unidade: FMRP

    Subjects: TERPENOS, CANNABIS, ANTIPSICÓTICOS, LOCOMOÇÃO, CATALEPSIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MOREIRA, Fabrício A. e GUIMARÃES, Francisco Silveira. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. European Journal of Pharmacology, v. 512, p. 199-205, 2005Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2005.02.040. Acesso em: 24 jul. 2024.
    • APA

      Moreira, F. A., & Guimarães, F. S. (2005). Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice. European Journal of Pharmacology, 512, 199-205. doi:10.1016/j.ejphar.2005.02.040
    • NLM

      Moreira FA, Guimarães FS. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice [Internet]. European Journal of Pharmacology. 2005 ; 512 199-205.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.ejphar.2005.02.040
    • Vancouver

      Moreira FA, Guimarães FS. Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice [Internet]. European Journal of Pharmacology. 2005 ; 512 199-205.[citado 2024 jul. 24 ] Available from: https://doi.org/10.1016/j.ejphar.2005.02.040

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024